The article describes point-of-care (POC) testing for sexually transmitted infections, including available assays, potential benefits, and the role of laboratory professionals in implementation.
Approach:
Testing model: POC tests are performed close to the patient, outside the traditional clinical laboratory, and typically provide results within minutes to an hour.
Available tests: Rapid antibody and antigen-antibody tests for syphilis and HIV have been used for years and can provide results in less than 30 minutes. Newer FDA-cleared, CLIA-waived molecular assays detect chlamydia and gonorrhea in approximately 20 minutes; some newer platforms also test for Mycoplasma genitalium and Trichomonas vaginalis.
Implementation: Pathologists and laboratory professionals contribute to test selection, implementation, quality assurance, and oversight.
Key Findings:
Results available during the same encounter can support diagnosis and treatment without depending on a later follow-up visit.
The article describes potential benefits including reduced loss to follow-up, less reliance on empiric treatment, and improved access for people facing barriers to conventional testing.
Accurate rapid testing may reduce reliance on syndromic treatment, support antimicrobial stewardship, and limit unnecessary antibiotic exposure.
POC tests for herpes simplex virus and human papillomavirus are not yet available.
Interpretation:
The article describes POC testing as a complement to centralized laboratory services, particularly where loss to follow-up is common or rapid treatment is important.
Limitations:
Molecular platforms may involve substantial cost and operational complexity.
Some assays have restrictions on specimen types, including limited approval for extragenital testing.
CLIA-waived tests still require staff training, competency assessment, and quality control.
Workflow, staffing, and testing volume may make implementation impractical in some settings.
Conclusion:
The article states that POC STI testing requires appropriate training, quality controls, and integration into health care systems.
UK pilot study finds that whole genome sequencing can uncover genetic conditions in children, leading to changes in clinical management and specialist care
An automated CT analysis tool identifies pancreatic cancer more than a year before clinical diagnosis, potentially opening new opportunities for early detection